Breaking News Instant updates and real-time market news.

PX

Praxair

, FBR

Fibria Celulose

$7.21

0.1 (1.41%)

08:31
10/06/16
10/06
08:31
10/06/16
08:31

Praxair signs long-term oxygen supply agreement with Fibria

Praxair, Inc. (PX), through its Brazilian subsidiary White Martins, has signed a long-term agreement expanding its supply of oxygen to Fibria Celulose S/A (FBR) in Tres Lagoas, Brazil. Through its Horizon 2 Project, Fibria is expanding its Tres Lagoas facility, located in the state of Mato Grosso do Sul. The expansion is expected to be completed in late 2017. Praxair's new plant, also expected to start up in late 2017, is designed to increase Fibria's productivity and support the company's expansion of this site. Fibria currently has global annual production capacity of 5.3 million tons of eucalyptus pulp and is seeking to increase its capacity to 7.25 million tons annually. Fibria's expansion will demand an additional 160 tons per day of oxygen, for use in the pulp delignification stage, also known as pre-bleaching pulp.

PX

Praxair

FBR

Fibria Celulose

$7.21

0.1 (1.41%)

  • 27

    Oct

PX Praxair

02/02/16
02/02/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Agnico Eagle (AEM) downgraded to Hold from Buy at Desjardins... Alere (ALR) downgraded to Hold from Buy at Canaccord... Antero Resources (AR) downgraded to Reduce from Neutral at SunTrust... Carbylan (CBYL) downgraded to Market Perform from Outperform at Leerink... Copa Holdings (CPA) downgraded to Hold from Buy at Deutsche Bank... Dominion (D) downgraded to Neutral from Buy at Citi... Duke Energy (DUK) downgraded to Market Perform from Outperform at Wells Fargo... Hain Celestial (HAIN) downgraded to Neutral from Overweight at Piper Jaffray... Integrated Device (IDTI) downgraded to Neutral from Buy at BofA/Merrill... Logitech (LOGI) downgraded to Underweight from Equal Weight at Morgan Stanley... Merus Labs (MSLI) downgraded to Sector Perform from Outperform at Scotiabank... New Gold (NGD) downgraded to Sell from Buy at Desjardins... Nokia (NOK) downgraded to Underperform from Buy at CLSA... Plantronics (PLT) downgraded to Underperform from Outperform at Raymond James... Pool Corp. (POOL) downgraded to Equal Weight from Overweight at Stephens... Praxair (PX) downgraded to Sector Weight from Overweight at KeyBanc... Rofin-Sinar (RSTI) downgraded to Neutral from Buy at Longbow... Southwestern Energy (SWN) downgraded to Neutral from Overweight at JPMorgan... Stifel cuts Twitter (TWTR) to Sell after noting Yahoo has significantly more users... Superior Energy (SPN) downgraded to In-Line from Outperform at Imperial Capital... Sysco (SYY) downgraded to Underweight from Equal Weight at Morgan Stanley... Telenor (TELNY) downgraded to Underperform from Neutral at Credit Suisse... Twitter (TWTR) downgraded to Sell from Hold at Stifel... Valeo (VLEEY) downgraded to Underweight from Equal Weight at Morgan Stanley.
03/24/16
FBCO
03/24/16
NO CHANGE
Target $117
FBCO
Neutral
Praxair assumed with a Neutral at Credit Suisse
Credit Suisse analyst Christopher Parkinson assumed coverage on Praxair with a Neutral rating and increased the price target to $117 from $107.
04/04/16
DBAB
04/04/16
DOWNGRADE
Target $120
DBAB
Hold
Praxair downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Begleiter downgraded Praxair to Hold but raised his price target for the shares to $120 from $114.
08/16/16
JEFF
08/16/16
NO CHANGE
Target $140
JEFF
Buy
Jefferies sees 20% probability of Praxair, Linde merger
Following the Wall Street Journal's report last night, Jefferies analyst Laurence Alexander pegs a potential merger between Praxair (PX) and Linde (LNEGY) at 20%. The analyst estimates Praxair could pay a 26% control premium, 50% equity, and still achieve an 8% return on invested capital in the third year and improve free cash flow per share by $1.70. Alexander has a Buy rating on Praxair with a $140 price target.
FBR Fibria Celulose
$7.21

0.1 (1.41%)

04/01/16
SCOT
04/01/16
UPGRADE
SCOT
Outperform
Fibria Celulose upgraded to Outperform from Sector Perform at Scotiabank
07/20/16
IBBA
07/20/16
DOWNGRADE
IBBA
Market Perform
Fibria Celulose downgraded to Market Perform from Outperform at Itau BBA
07/21/16
BOFA
07/21/16
DOWNGRADE
BOFA
Neutral
Fibria Celulose downgraded to Neutral from Buy at BofA/Merrill
08/03/16
SBSH
08/03/16
DOWNGRADE
SBSH
Neutral
Fibria Celulose downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

CORI

Corium

$10.88

0.03 (0.28%)

07:10
09/26/17
09/26
07:10
09/26/17
07:10
Initiation
Corium initiated  »

Corium initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FDS

FactSet

$170.81

2.2 (1.30%)

07:10
09/26/17
09/26
07:10
09/26/17
07:10
Earnings
FactSet reports Q4 adj. EPS $1.90, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

LNG

Cheniere Energy

$44.12

0.64 (1.47%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$4.37

0.15 (3.55%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Hot Stocks
Chesapeake sees Q3 production 542,000 boe per day »

Chesapeake Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

KTOS

Kratos Defense

$12.72

-0.28 (-2.15%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Kratos Defense receives $9.7M in contract awards »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVGN

Evogene

$4.54

0.23 (5.34%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Evogene reports 'positive' results in 2nd year field trials in banana »

Evogene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Axovant Phase 3 Alzheimer's study misses co-primary endpoints »

Axovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AST

Asterias

$3.25

0.05 (1.56%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Asterias receives regulatory clearance to start AST-VAC2 clinical trial »

Asterias Biotherapeutics,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MDXG

MiMedx

$12.35

-0.28 (-2.22%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
MiMedx announces confidential lawsuit settlement with terminated employee »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 13

    Nov

  • 14

    Nov

DRI

Darden

$83.14

0.26 (0.31%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Darden reports Q1 Olive Garden same-restaurant sales up 1.9% »

Reports Q1 same…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AGN

Allergan

$211.61

6.96 (3.40%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Recommendations
Allergan analyst commentary  »

Allergan weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZRE

Azure Power

$16.18

0.18 (1.13%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Hot Stocks
Azure Power awarded 260 MW solar project in Gujarat »

Azure Power announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEES

H&E Equipment

$26.97

-0.2 (-0.74%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Initiation
H&E Equipment initiated  »

H&E Equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$0.94

0.093 (10.98%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Hot Stocks
Northern Oil and Gas announces settlement with former CEO »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden reports Q1 Olive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BTX

BioTime

$2.72

-0.08 (-2.86%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
BioTime announces 'positive' secondary, long-term data from Renevia trial »

BioTime announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MBRX

Moleculin Biotech

$2.41

-0.07 (-2.82%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Moleculin Biotech announces FDA approval of Annamycin IND »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNCA

Genocea

$5.33

0.04 (0.76%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Downgrade
Genocea rating change  »

Genocea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Darden reports Q1 blended same-restaurant sales from legacy brands up 1.7% »

Q1 same-restaurant sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Earnings
Darden backs FY18 adjusted cont ops EPS view $4.38-$4.50, consensus $4.47 »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:01
09/26/17
09/26
07:01
09/26/17
07:01
Hot Stocks
Akebia saya Phase 2 vadadustat study confirmed findings from previous studies »

Akebia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:00
09/26/17
09/26
07:00
09/26/17
07:00
General news
FX Update: The dollar has been in rally mode »

FX Update: The dollar has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.